[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100552468":3},{"organization":4,"armGroups":7,"interventions":25,"overallOfficials":34,"centralContacts":42,"locations":51,"responsibleParty":83,"collaborators":85,"id":88,"slug":89,"hasResults":90,"nctId":91,"briefTitle":92,"officialTitle":93,"acronym":94,"eligibilityCriteria":95,"healthyVolunteers":90,"sex":96,"minAge":97,"maxAge":98,"enrollmentInfo":99,"targetDuration":12,"studyType":102,"phases":103,"briefSummary":105,"conditions":106,"keywords":111,"overallStatus":54,"whyStopped":12,"lastUpdateSubmitDate":120,"lastUpdatePostDateStruct":121,"startDateStruct":124,"completionDateStruct":126,"leadSponsor":128,"locationsCount":129},{"fullName":5,"class":6},"Odense University Hospital","OTHER",[8,13,19],{"label":9,"type":10,"description":11,"interventionNames":12},"PERIOD 1: Point-of-care fingerstick glucose monitoring = standard care","NO_INTERVENTION","Subjects' blood glucose levels are monitored using point-of-care fingerstick capillary glucose monitoring (standard care), which is conducted by surgical ward nurses according to a predefined schedule. Diabetes treatment management is overseen by specific in-house diabetes nurses. Treatment decisions are based on point-of-care fingerstick capillary glucose values.",null,{"label":14,"type":15,"description":16,"interventionNames":17},"PERIOD 2: Glucose monitoring system as point-of-care = study intervention","ACTIVE_COMPARATOR","The sensor from the continuous glucose monitoring system is scanned by surgical nurses as point-of-care according to the predefined schedule, as in standard care. Monitoring is conducted by surgical ward nurses.\n\nDiabetes treatment management is overseen by specific in-house diabetes nurses. Diabetes nurses' treatment decisions are based on the continuous glucose monitoring system values.",[18],"Device: Abbott FreeStyle Libre System 2 Plus",{"label":20,"type":21,"description":22,"interventionNames":23},"PERIOD 3: Point-of care fingerstick glucose monitoring = standard care + blinded sensor","EXPERIMENTAL","PERIOD 3: Same as for period 1, but with a blinded sensor (FreeStyle Libre Pro). The data from the blinded sensors are concealed from both participants and nurses and will be used for comparison with the experimental arm.\n\nThis study period is only conducted at OUH.",[24],"Device: Abbott Freestyle Libre Pro",[26,31],{"type":27,"name":28,"description":29,"armGroupLabels":30,"otherNames":12},"DEVICE","Abbott FreeStyle Libre System 2 Plus","The sensor is placed subcutaneously at the back of the participant's upper arm with one insertion and measures the subcutaneous glucose concentration.",[14],{"type":27,"name":32,"description":29,"armGroupLabels":33,"otherNames":12},"Abbott Freestyle Libre Pro",[20],[35,39],{"name":36,"affiliation":37,"role":38},"Karoline Schousboe, MD, PhD","Steno Diabetes Center Odense, Odense University Hospital","STUDY_CHAIR",{"name":40,"affiliation":41,"role":38},"Helen Schultz, RN, PhD","The Department of Surgery, Odense University Hospital",[43,47],{"name":40,"role":44,"phone":45,"phoneExt":12,"email":46},"CONTACT","+4522401513","Helen.Schultz@rsyd.dk",{"name":36,"role":44,"phone":48,"phoneExt":49,"email":50},"+4524349740","0045","Karoline.Schousboe@rsyd.dk",[52,68],{"facility":53,"status":54,"city":55,"state":55,"zip":56,"country":57,"countryCode":58,"cosmosGeoPoint":59,"geoPoint":64,"contacts":65},"Department of Surgery, Zealand University Hospital","RECRUITING","Køge","4600","Denmark","DK",{"type":60,"coordinates":61},"Point",[62,63],12.18214,55.45802,{"lat":63,"lon":62},[66],{"name":67,"role":44,"phone":12,"phoneExt":12,"email":12},"Tine Lumbye Thomsen, RN, MCN",{"facility":69,"status":54,"city":70,"state":70,"zip":71,"country":57,"countryCode":58,"cosmosGeoPoint":72,"geoPoint":76,"contacts":77},"The Department of Surgery, Odense Univeristy Hospital","Odense","5000",{"type":60,"coordinates":73},[74,75],10.38831,55.39594,{"lat":75,"lon":74},[78,79],{"name":40,"role":44,"phone":45,"phoneExt":12,"email":46},{"name":80,"role":44,"phone":81,"phoneExt":12,"email":82},"Line Abrahamsen, RN, MCN","+4565412244","line.abrahamsen@rsyd.dk",{"type":84,"investigatorFullName":12,"investigatorTitle":12,"investigatorAffiliation":12,"oldNameTitle":12,"oldOrganization":12},"SPONSOR",[86],{"name":87,"class":6},"Zealand University Hospital","100552468","continuous-bloodsugar-monitoring-system-with-a-sensor-compared-to-fingerstick-bloodsugar-monitoring-100552468",false,"NCT06473480","Continuous Bloodsugar Monitoring System With a Sensor Compared to Fingerstick Bloodsugar Monitoring","Continuous GLUCOse Monitoring System With a SENSor Compared to Fingerstick Glucose Monitoring in Surgical Wards (GLUCOSENS)","GLUCOSENS","Inclusion Criteria:\n\n* Hospitalized patients (≥ 18 years old) in surgical wards\n* Glucose measurements at least 4 times (OUH) and 3 times (SUH) daily for at least three days, prescribed by surgeon\n* Expected hospitalization for at least three days\n* Communicates in Danish\n* Signed a declaration of consent to study participation\n* At risk of hypo- and hyperglycemia (with or without a diabetes diagnosis)\n* Specific for substudy 4 inclusion criteria as above with the following add on: Patients being treated with insulin at discharge and patients residing within the OUH admission area.\n\nExclusion Criteria:\n\n* Cognitively impaired patients\n* Indication for glucose monitoring solely because of parenteral nutrition treatment\n* Patients admitted with a CGMS\n* Patients from the point-of-care fingerstick capillary glucose monitoring group cannot be included in the continuous glucose monitoring system group\n\nEligibility criteria solely for substudy 7\n\nInclusion Criteria:\n\n* Nursing staff with at least one month of experience with both point-of-care fingerstick capillary glucose monitoring and continuous glucose monitoring system and are registered nurses or certified nursing assistants","ALL","18 Years","110 Years",{"count":100,"type":101},329,"ESTIMATED","INTERVENTIONAL",[104],"NA","This clinical trial aims to compare a continuous glucose monitoring system with traditional fingerstick blood glucose monitoring. The study focuses on adult patients in general surgical wards who need regular blood glucose checks due to the risk of low or high blood sugar levels.\n\nThe goal is to learn if using a continuous glucose monitoring system is better than fingerstick monitoring in managing glucose levels, preventing complications, improving patient satisfaction and experience, reducing nursing staff workload, and improving nursing staff' experience. The study also compares the accuracy of glucose readings from the continuous glucose monitoring system with those from fingerstick tests and blood samples.\n\nThe hypothesis is that CGMS is accurate and effective for monitoring glucose levels in surgical patients. This could lead to better blood sugar control, fewer complications, shorter hospital stays, and improved experiences for both patients and nursing staff.",[107,108,109,110],"Diabetes Mellitus","Hypoglycemia (Diabetic)","Hypoglycemia Night","Hyperglycemia",[112,113,114,115,116,117,118,119],"Blood glucose monitoring","point-of-care fingerstick capillary glucose monitoring","continuous glucose monitoring system","Patient satisfaction","Patient experience","Nursing staff's workload","Nursing staff's experience","accuracy","2025-03-31",{"date":122,"type":123},"2025-04-03","ACTUAL",{"date":125,"type":123},"2024-06-26",{"date":127,"type":101},"2025-12-31",{"name":5,"class":6},2]